# Ami Polymer

Source: https://en.bioecon.ru/companies/ami-polymer/
Updated: 2026-06-24

- Country: India

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | ₹159.92 Cr for FY 2025 | https://www.thecompanycheck.com/company/ami-polymer-private-limited/U25190MH2003PTC139089 |
| Capacity | 25,000 tonnes per month | https://www.amipolymer.com/why-choose-us |
| Certification | ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 27001:2013, ISO 27001:2022, ISO 13485:2016, NSF-51, BPOG-standardized extractables, USP Class VI | https://pharmaceuticalbusinessreview.com/ami-polymer-provides-innovative-polymer-solutions-for-affordable-healthcare/, https://www.amipolymer.com/, https://www.amipolymer.com/about/, https://www.amipolymer.com/why-choose-us |
| Regulatory approval | USFDA DMFs (#26201, 32560, 32558, 32559, 32561, 32549), FDA 21 CFR, EP 3.1.9, ADI Free, RoHS | https://pharmaceuticalbusinessreview.com/ami-polymer-provides-innovative-polymer-solutions-for-affordable-healthcare/, https://www.amipolymer.com/about/ |
| Production site | Silvassa (Masat and Kala facilities), India | https://pharmaceuticalbusinessreview.com/ami-polymer-provides-innovative-polymer-solutions-for-affordable-healthcare/, https://www.amipolymer.com/about/ |
| Headcount | 283 to 360 employees [medium confidence] | https://www.amipolymer.com/about/, https://www.emis.com/php/company-profile/IN/Ami_Polymer_Private_Limited_en_3994091.html, https://www.thecompanycheck.com/company/ami-polymer-private-limited/U25190MH2003PTC139089 |

Independent sources: emis.com, pharmaceuticalbusinessreview.com, thecompanycheck.com

## Technologies

- [Single-use assemblies](https://en.bioecon.ru/technology/single-use-assemblies/)